Scott Nelson Live

Scott Nelson Live

By Scott NelsonBusinessEntrepreneurship
Download on the App Store

All Scott Nelson Live episodes

  • The Most Important Piece of Advice for Raising Medtech Venture Capital: Interview with Sean Saint, Founder of Companion Medical

    In this episode, we caught up with Sean Saint, the CEO of Companion Medical, which recently sold to Medtronic. Sean has more than 20 years of engineering experience in medical devices and various start-ups. Here are a few topics we covered in this interview:

    • How Sean and his team at Companion Medical came up with the idea for the InPen.

    • Sean's advice for raising money from medtech investors.

    • Companion Medical's insurance and reimbursement strategy for the InPen.

    • 15 min
    • How to Fund Your Medical Device Startup: Interview with Rich Ferrari, Managing Director of De Novo Ventures

      This interview brings us to the end of a throwback mini-series that I’ve been releasing over the past few months with some of my favorite Medsider guests of all time.

      On this particular episode, I chatted with Rich Ferrari, Managing Director of De Novo Ventures, and one of the most well-known VCs in the Medtech space. Here are some of the points we covered:

      • Novel ways to fund early-stage medical device companies.

      • The metrics that are most important when it comes to early-stage versus late-stage medtech investing.

      • Why does the FDA “runway” seem to get longer and longer over time?

      • How Rich identifies and validates whether an idea is truly disruptive.

      • 38 min
      • How to Enhance your Medical Device Approval Process: Interview with Sheila Heyer, President of Heyer Regulatory Solutions

        We're coming to the end of the throwback mini-series that I’ve been releasing over the past few months with some of my favorite guests of all time.

        In this discussion with Sheila Heyer, President of Heyer Regulatory Solutions and former VP of Global Regulatory Affairs at Boston Scientific, we learn where medical device companies are missing the mark when it comes to the FDA approval process. Here are some of the things we chatted about:

        • The three most important steps you can take right now to get your medical device approved faster.

        • Quality submissions and solid relationships: the importance of honing these two concepts in order to enhance your regulatory approval process.

        • The key characteristics that great medtech regulatory professionals all have in common.

        • 37 min
        • What it Takes to Get a Medtech VC to Say Yes: Interview with Lisa Suennen

          This interview is a continuation of a throwback mini-series that I’ve been releasing over the past few weeks with some of my favorite guests of all time.

          One of which is Lisa Suennen, who was then a Managing Member of Psilos Group, a healthcare-focused venture capital firm with approximately $600 million under management. Although this discussion is several years old and the audio quality isn’t the best, the insights Lisa provides are timeless. Here are some of the things we covered:

          • What does Lisa think when the goal of physicians is to “dagger historical price lists."

          • Why Lisa and her partners at the Psilos Group favor late-stage deals.

          • Corporate venture capital arms: friend or foe? 

          • And if you’re an early-stage medical device company, what is the best way to get the attention of Lisa Suennen and her peers in the VC world?

          • 43 min
          • The Art of Medical Device Reimbursement: Interview with Randel Richner, Founder of Neocure Group

            This interview is a continuation of a throwback mini-series I’ve been releasing over the past few weeks with some of my favorite guests.

            On this particular episode, I chatted with Randel Richner, a true expert in healthcare economics and reimbursement.  At the time of this interview, she was with Neocure Group, a company she founded and later sold to Intralign. Although this discussion is several years old and the audio quality isn’t ideal, Randel's insights are timeless. Here are some of the things we covered:

            • A case study of how Randel helped save a medical device company from severe reimbursement implications.

            • Randel’s unique “orchestra score” philosophy and how it aids in streamlining reimbursement strategies.

            • The importance of defining the difference between how hospitals get paid and how physicians get paid.

            • And what Randel means by the statement “comparative effectiveness is a code word for cost-effectiveness”.

            • 34 min
            • What Medtech Venture Capitalists Want to See in Your Startup

              This interview is part of a throwback mini-series to several years ago when I chatted with Kevin Bitterman, who at the time, was with Polaris Venture Partners. He’s now a partner with Atlas Venture, but the lessons you can glean from this discussion still hold true. Namely:

              • What medtech venture capitalists like to see in a startup and how these early-stage medical device companies can best position themselves for success. 

              • What requirements would make for an attractive IPO opportunity?

              • What questions should medtech startups have already answered before approaching a potential buyer?

              • And in terms of a potential exit, what is more, important for a medical device startup – clinical data or commercial traction?

              • 33 min
              • 4 Ideas Your Medical Device Company is Missing from its Marketing Strategy: Interview with Joe Hage, Chairman of the Medical Devices Group

                This interview is part of a throwback mini-series from several years ago when I chatted with my good friend, Joe Hage. He’s the CEO of Medical Marcom and Chairman of the Medical Devices Group, a community of over 350,000 medical device members. In this entertaining interview, here are some of the things we talked about:

                • How Joe, with a limited medical device industry background, helped Cardiac Science become a medtech marketing leader.

                • Why Joe thinks search engine optimization (SEO) is among the most important elements for your marketing mix.

                • How you can use editorials to demonstrate medical device industry leadership.

                • And why sending prospects to your website homepage may not be the best idea.

                • 47 min
                • The Incredible Story of How Dr. David Albert Brought the AliveCor ECG iPhone App to Market

                  This interview is a throwback to several years ago when I chatted with Dr. David Albert about his incredible journey in bringing the AliveCor ECG app to market. Here are a few things we covered:

                  • The amazing story of how AliveCor’s iPhone app helped save a man’s life while on an airplane!

                  • The roller coaster ride Dr. Albert experienced in his pursuits to develop the ECG app.

                  • Five key lessons you can learn from Dr. Albert’s experiences. 

                  • And his timeliness advice for ambitious doers, which includes the following: believe in your ideas don’t be afraid to swim against the stream.

                  • 50 min
                  • How to Win with Contract Manufacturers: Interview with Travis Sessions, CEO of Biomerics

                    On this episode, our guest is Travis Sessions, the Founder and Chief Executive Officer of Biomerics, a leading mid-market interventional device contract manufacturer. He's also a Managing Partner of Med Venture Holdings, a unique medtech growth equity investor. With over 20 years of business management experience, Travis has successfully built and grown multiple medical device technology companies during his career. He got his start professionally at Dow Chemical and has held management positions at Microsoft and Parker Hannifin Corporation. Travis has a B.S. in Chemical Engineering from Brigham Young University and a Master’s in Business Administration from the University of Michigan.

                    Interview Highlights with Travis Sessions:

                    • Macro trends within the medtech market, including Travis’ thoughts on the future.

                    • Key differences between contract manufacturers (CMs) and large original equipment manufacturers (OEMs).

                    • Critical things that OEMs should look for when identifying and working with CMs.

                    • The origin story of Med Venture Holdings.

                    • What Travis looks for when vetting early-stage medtech ideas.

                    • Critical functions that need to be in place for a medical device startup to be acquired.

                    • Travis’ favorite book, the mentor he most admires, and the advice he’d give to his 30-year-old self.

                    • 48 min
                    • Clinical Trials as Revenue Drivers: Interview with Matthew Amsden, CEO of ProofPilot

                      In this episode, our guest is Matthew Amsden, the Founder, and CEO of ProofPilot, a platform designed to help people design, launch and participate in clinical trials.

                      ProofPilot’s mission statement revolves around making it incredibly easy to run scientifically-valid research studies. They’re dedicated to making research study participation accessible, interesting, and fun.      

                      In this discussion with Matthew, we chatted about the importance and feasibility of virtual clinical trials, how they can potentially become a revenue driver, the origin story of ProofPilot, and why their hybrid model is so popular.

                      Interview Highlights with Matthew Amsden

                      • Who is Matthew Amsden and where did the idea for ProofPilot begin?    

                      • The importance of letting early customers try product iterations.

                      • How clinical studies can become a revenue driver. 

                      • Various types of clinical trials and how they’re conducted on the ProofPilot platform.

                      • Risky and costly approaches to traditional clinical studies.     

                      • The synergy between data, compliance, and incentives.

                      • How a virtual, hybrid model can solve problems when it comes to traditional clinical trials. 

                      • Matthew’s favorite business book, the mentor he most admires, and the advice he’d give to his 30-year-old self.

                      • 1 hr